Wag! Reports Record Second Quarter 2023 Results
Highest Service Revenue Quarter To Date First Quarter of Adjusted EBITDA Profitability Raises Previously Announced…
Social Media
Sofwave Medical Reports Second Quarter and First Half 2023 Financial Results and Recent Business Highlights
– Second quarter revenue of $12.4M, +53% year-over-year growth– Second quarter pulse recurring revenue of…
Sofwave Medical Reports Second Quarter and First Half 2023 Financial Results and Recent Business Highlights
– Second quarter revenue of $12.4M, +53% year-over-year growth– Second quarter pulse recurring revenue of…
Orchestra BioMed™ Granted FDA Approval of IDE for U.S. Pivotal Study of Virtue® Sirolimus AngioInfusion Balloon™ in Patients with Coronary In-Stent Restenosis
Virtue® Sirolimus AngioInfusion Balloon (“SAB”) is the only non-coated angioplasty system providing protected delivery of…
Orchestra BioMed™ Granted FDA Approval of IDE for U.S. Pivotal Study of Virtue® Sirolimus AngioInfusion Balloon™ in Patients with Coronary In-Stent Restenosis
Virtue® Sirolimus AngioInfusion Balloon (“SAB”) is the only non-coated angioplasty system providing protected delivery of…
Cogent Biosciences Reports Recent Business Highlights and Second Quarter 2023 Financial Results
Initial clinical results from Phase 2 SUMMIT trial in NonAdvSM along with updated data from…
Cogent Biosciences Reports Recent Business Highlights and Second Quarter 2023 Financial Results
Initial clinical results from Phase 2 SUMMIT trial in NonAdvSM along with updated data from…
Monopar Provides Encouraging Camsirubicin Clinical Data Update
WILMETTE, Ill., Aug. 08, 2023 (GLOBE NEWSWIRE) — Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical…
Monopar Provides Encouraging Camsirubicin Clinical Data Update
WILMETTE, Ill., Aug. 08, 2023 (GLOBE NEWSWIRE) — Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical…
Amarin And Neopharm Announce Exclusive Commercialization Agreement for VAZKEPA® (Icosapent Ethyl) in Israel
— Agreement Follows Recent Regulatory Approval in Israel of VAZKEPA® to Reduce the Risk of…
Amarin And Neopharm Announce Exclusive Commercialization Agreement for VAZKEPA® (Icosapent Ethyl) in Israel
— Agreement Follows Recent Regulatory Approval in Israel of VAZKEPA® to Reduce the Risk of…
Mithra and Gedeon Richter Sign Supply Agreement for Production of API for Estelle® and Donesta®
Mithra and Gedeon Richter Sign Supply Agreement for Production of API for Estelle® and Donesta®…
Scottish Medicines Consortium Accepts VAZKEPA® (icosapent ethyl) to Help Reduce Cardiovascular Risk for Patients in Scotland(1)
— VAZKEPA® (icosapent ethyl) accepted by the Scottish Medicines Consortium (SMC) for restricted use within…
Scottish Medicines Consortium Accepts VAZKEPA® (icosapent ethyl) to Help Reduce Cardiovascular Risk for Patients in Scotland(1)
— VAZKEPA® (icosapent ethyl) accepted by the Scottish Medicines Consortium (SMC) for restricted use within…
FDA Approves ZURZUVAE™ (zuranolone), the First and Only Oral Treatment Approved for Women with Postpartum Depression, and Issues a Complete Response Letter for Major Depressive Disorder
Postpartum depression (PPD) approval based on results from two Phase 3 clinical trials; in the…
ISG to Publish Reports on Intelligent Automation Providers
Upcoming ISG Provider Lens™ reports will assess providers facilitating intelligent, AI-powered automation to transform and…
Fisker Showcases Future Vehicle Lineup at First-ever Product Vision Day
Fisker showcases vision for sustainable all-electric vehicle lineup through 2026. Vehicles include Ronin, PEAR, Alaska,…
CVS Health to Begin Nationwide In-Store Sales of Biomerica’s EZ Detect™ Colorectal Disease Screening Test
Over 7,000 CVS Pharmacy Stores to sell the EZ Detect™ Test Simple 2 minute at-home…
CVS Health to Begin Nationwide In-Store Sales of Biomerica’s EZ Detect™ Colorectal Disease Screening Test
Over 7,000 CVS Pharmacy Stores to sell the EZ Detect™ Test Simple 2 minute at-home…
InvestmentPitch Media Video Features FSD Pharma’s Definitive Agreement Granting Exclusive Rights for Launch of UNBUZZD, a Revolutionary Rapid Alcohol Detoxification Drink
VANCOUVER, British Columbia, Aug. 03, 2023 (GLOBE NEWSWIRE) — FSD Pharma Inc. (NASDAQ:HUGE) (CSE:HUGE) (FSE:0K9A),…